The development of vaginal microbicides for the prevention of HIV transmission

PLoS Med. 2005 May;2(5):e142. doi: 10.1371/journal.pmed.0020142. Epub 2005 May 31.

Abstract

Given that we still do not have an effective vaccine against HIV, the development of novel biomedical methods for preventing HIV transmission remains a top priority in controlling the HIV pandemic.

Publication types

  • Review

MeSH terms

  • Administration, Intravaginal
  • Anti-Infective Agents / administration & dosage*
  • Anti-Infective Agents / therapeutic use*
  • Anti-Retroviral Agents / administration & dosage
  • Anti-Retroviral Agents / therapeutic use
  • Clinical Trials as Topic
  • Coitus
  • Female
  • HIV Infections / prevention & control*
  • HIV Infections / transmission*
  • Humans
  • Patient Advocacy
  • Private Sector
  • Public Sector
  • Surface-Active Agents / administration & dosage
  • Surface-Active Agents / therapeutic use

Substances

  • Anti-Infective Agents
  • Anti-Retroviral Agents
  • Surface-Active Agents